RE:RE:RE:RE:RE:RE:RE:From $0.52 to $28.00 in 12 months or $3.5 to $23 in 3 monthsIn contrast to Ambryx, ONCY has 2 Phase 3 ready registration studies - in mPDAC and mBC, which each have a particular value higher than Ambryx single Phase 1/2 clinical trial that brought the company $ 2 Billion.